Arsenic trioxide inhibits cell growth and motility via up-regulation of let-7a in breast cancer cells

Reference

• Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi:10.3322/caac.21387.
   PubMed Web of Science ®Google Scholar
• Wu DD, Lau ATY, Yu FY, Cai NL, Dai LJ, Ok Kim M, Jin DY, Xu YM. Extracellular signal-regulated kinase 8-mediated NF-kappaB activation increases sensitivity of human lung cancer cells to arsenic trioxide. Oncotarget. 2017;8:49144–49155.
   PubMed Web of Science ®Google Scholar
• Noguera NI, Pelosi E, Angelini DF, Piredda ML, Guerrera G, Piras E, Battistini L, Massai L, Berardi A, Catalano G, et al. High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro. Oncotarget. 2017;8:32550–32565.
   PubMed Web of Science ®Google Scholar
• Tai S, Xu L, Xu M, Zhang L, Zhang Y, Zhang K, Liang C. Combination of Arsenic trioxide and Everolimus (Rad001) synergistically induces both autophagy and apoptosis in prostate cancer cells. Oncotarget. 2017;8:11206–11218.
   PubMed Web of Science ®Google Scholar
• Moghaddaskho F, Eyvani H, Ghadami M, Tavakkoly-Bazzaz J, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH. Demethylation and alterations in the expression level of the cell cycle-related genes as possible mechanisms in arsenic trioxide-induced cell cycle arrest in human breast cancer cells. Tumour Biol. 2017;39:1010428317692255. doi:10.1177/1010428317692255. PMID:28218039
   PubMedGoogle Scholar
• Hoffman EA, Gizelska K, Mirowski M, Mielicki W. Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro. Contemp Oncol (Pozn). 2015;19:108–112.
   PubMed Web of Science ®Google Scholar
• Zhang H, Gu H, Li L, Ren Y, Zhang L. EZH2 mediates ATO-induced apoptosis in acute myeloid leukemia cell lines through the Wnt signaling pathway. Tumour Biol. 2016;37:5919–5923.
   PubMedGoogle Scholar
• Bakhshaiesh TO, Armat M, Shanehbandi D, Sharifi S, Baradaran B, Hejazi MS, Samadi N. Arsenic trioxide promotes paclitaxel cytotoxicity in resistant breast cancer cells. Asian Pac J Cancer Prev. 2015;16:5191–5197. doi:10.7314/APJCP.2015.16.13.5191.
   PubMedGoogle Scholar
• Kasukabe T, Okabe-Kado J, Kato N, Honma Y, Kumakura S. Cotylenin A and arsenic trioxide cooperatively suppress cell proliferation and cell invasion activity in human breast cancer cells. Int J Oncol. 2015;46:841–848. doi:10.3892/ijo.2014.2760.
   PubMed Web of Science ®Google Scholar
• Guilbert C, Annis MG, Dong Z, Siegel PM, Miller WH, Jr., Mann KK. Arsenic trioxide overcomes rapamycin-induced feedback activation of AKT and ERK signaling to enhance the anti-tumor effects in breast cancer. PLoS One. 2013;8:e85995. doi:10.1371/journal.pone.0085995. PMID:24392034
   PubMed Web of Science ®Google Scholar
• Liu W, Gong Y, Li H, Jiang G, Zhan S, Liu H, Wu Y. Arsenic trioxide-induced growth arrest of breast cancer MCF-7 cells involving FOXO3a and IkappaB kinase beta expression and localization. Cancer Biother Radiopharm. 2012;27:504–512. doi:10.1089/cbr.2012.1162.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhang Y, Yang L, Cai B, Li J, Zhou Y, Yin L, Yang BF, Lu YJ. Arsenic trioxide induces the apoptosis of human breast cancer MCF-7 cells through activation of caspase-3 and inhibition of HERG channels. Exp Ther Med. 2011;2:481–486. doi:10.3892/etm.2011.224.
   PubMed Web of Science ®Google Scholar
• Kasinski AL, Slack FJ. Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11:849–864.
   PubMed Web of Science ®Google Scholar
• Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857–866. doi:10.1038/nrc1997.
   PubMed Web of Science ®Google Scholar
• van Kouwenhove M, Kedde M, Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer. 2011;11:644–656. doi:10.1038/nrc3107.
   PubMed Web of Science ®Google Scholar
• Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg. 2010;251:499–505. doi:10.1097/SLA.0b013e3181cc939f.
   PubMed Web of Science ®Google Scholar
• Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. Breast Cancer Res. 2012;14:R14. doi:10.1186/bcr3098. PMID:22251626
   PubMed Web of Science ®Google Scholar
• Liu Y, Li H, Feng J, Cui X, Huang W, Li Y, Su F, Liu Q, Zhu J, Lv X, et al. Lin28 induces epithelial-to-mesenchymal transition and stemness via downregulation of let-7a in breast cancer cells. PLoS One. 2013;8:e83083. doi:10.1371/journal.pone.0083083. PMID:24349438
   PubMed Web of Science ®Google Scholar
• Lyu S, Yu Q, Ying G, Wang S, Wang Y, Zhang J, Niu Y. Androgen receptor decreases CMYC and KRAS expression by upregulating let-7a expression in ER-, PR-, AR+ breast cancer. Int J Oncol. 2014;44:229–237. doi:10.3892/ijo.2013.2151.
   PubMed Web of Science ®Google Scholar
• Liang H, Li X, Wang L, Yu S, Xu Z, Gu Y, Pan Z, Li T, Hu M, Cui H, et al. MicroRNAs contribute to promyelocyte apoptosis in As2O3-treated APL cells. Cell Physiol Biochem. 2013;32:1818–1829. doi:10.1159/000356615.
   PubMed Web of Science ®Google Scholar
• Wang X, Jiang F, Mu J, Ye X, Si L, Ning S, Li Z, Li Y. Arsenic trioxide attenuates the invasion potential of human liver cancer cells through the demethylation-activated microRNA-491. Toxicol Lett. 2014;227:75–83. doi:10.1016/j.toxlet.2014.03.016.
   PubMed Web of Science ®Google Scholar
• Chen S, Zhu L, Huang J, Cai Y, Lu X, Yang Q, Wu Q, Chen C, Wang Z. Arsenic trioxide targets miR-125b in glioma cells. Curr Pharm Des. 2014;20:5354–5361. doi:10.2174/1381612820666140128204132.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu JH, Han F, Huang JM, Shi SY, Gu RD, Chen XL, He B. Arsenic trioxide induced apoptosis in retinoblastoma cells by abnormal expression of microRNA-376a. Neoplasma. 2013;60:247–253. doi:10.4149/neo_2013_033.
   PubMed Web of Science ®Google Scholar
• Shidfar F, Ghaffari SH, Tavoosidana G, Hosseini E, Alimoghaddam K, Ghavamzadeh A. Arsenic trioxide Alters the MicroRNA Expression Profile of U87 glioblastoma. Anticancer Agents Med Chem. 2015;16:247–258. doi:10.2174/1871520615666150629100752.
   PubMed Web of Science ®Google Scholar
• Wang J, Li Y, Jiang C. MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel. J Mol Neurosci. 2015;55:985–994. doi:10.1007/s12031-014-0455-8.
   PubMed Web of Science ®Google Scholar
• Ji H, Li Y, Jiang F, Wang X, Zhang J, Shen J, Yang X. Inhibition of transforming growth factor beta/SMAD signal by MiR-155 is involved in arsenic trioxide-induced anti-angiogenesis in prostate cancer. Cancer Sci. 2014;105:1541–1549. doi:10.1111/cas.12548.
   PubMed Web of Science ®Google Scholar
• Jiang F, Wang X, Liu Q, Shen J, Li Z, Li Y, Zhang J. Inhibition of TGF-beta/SMAD3/NF-kappaB signaling by microRNA-491 is involved in arsenic trioxide-induced anti-angiogenesis in hepatocellular carcinoma cells. Toxicol Lett. 2014;231:55–61. doi:10.1016/j.toxlet.2014.08.024.
   PubMed Web of Science ®Google Scholar
• Chang YW, Chen MW, Chiu CF, Hong CC, Cheng CC, Hsiao M, Chen CA, Wei LH, Su JL. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-kappaB signaling in cervical cancer. Ann Surg Oncol. 2014;21 Suppl 4:S687–S695.
   PubMedGoogle Scholar
• Si L, Jiang F, Li Y, Ye X, Mu J, Wang X, Ning S, Hu C, Li Z. Induction of the mesenchymal to epithelial transition by demethylation- activated microRNA-200c is involved in the anti-migration/invasion effects of arsenic trioxide on human breast cancer cells. Mol Carcinog. 2015;54:859–869. doi:10.1002/mc.22157.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang L, Yin C, An B, Hao Y, Wei T, Li L, Song G. Arsenic trioxide inhibits breast cancer cell growth via microRNA-328/hERG pathway in MCF-7 cells. Mol Med Rep. 2015;12:1233–1238.
   PubMed Web of Science ®Google Scholar
• Zhang S, Ma C, Pang H, Zeng F, Cheng L, Fang B, Ma J, Shi Y, Hong H, Chen J, et al. Arsenic trioxide suppresses cell growth and migration via inhibition of miR-27a in breast cancer cells. Biochem Biophys Res Commun. 2016;469:55–61. doi:10.1016/j.bbrc.2015.11.071.
   PubMed Web of Science ®Google Scholar
• Mansoori B, Mohammadi A, Shirjang S, Baghbani E, Baradaran B. Micro RNA 34a and let-7a expression in human breast cancers is associated with apoptotic expression genes. Asian Pac J Cancer Prev. 2016;17:1887–1890.
   PubMedGoogle Scholar
• Wielgos ME, Rajbhandari R, Cooper TS, Wei S, Nozell S, Yang ES. Let-7 Status Is Crucial for PARP1 Expression in HER2-Overexpressing Breast Tumors. Mol Cancer Res. 2017;15:340–347. doi:10.1158/1541-7786.MCR-16-0287-T.
   PubMed Web of Science ®Google Scholar
• Isanejad A, Alizadeh AM, Amani Shalamzari S, Khodayari H, Khodayari S, Khori V, Khojastehnjad N. MicroRNA-206, let-7a and microRNA-21 pathways involved in the anti-angiogenesis effects of the interval exercise training and hormone therapy in breast cancer. Life Sci. 2016;151:30–40. doi:10.1016/j.lfs.2016.02.090.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang YX, Zhang DZ, Fang XJ, Sun PS, Xue HC. Let-7a mimic attenuates CCL18 induced breast cancer cell metastasis through Lin 28 pathway. Biomed Pharmacother. 2016;78:301–307. doi:10.1016/j.biopha.2016.01.028.
   PubMed Web of Science ®Google Scholar
• Sun X, Jiang S, Liu J, Wang H, Zhang Y, Tang SC, Wang J, Du N, Xu C, Wang C, et al. MiR-208a stimulates the cocktail of SOX2 and beta-catenin to inhibit the let-7 induction of self-renewal repression of breast cancer stem cells and formed miR208a/let-7 feedback loop via LIN28 and DICER1. Oncotarget. 2015;6:32944–32954. doi:10.18632/oncotarget.5079.
   PubMed Web of Science ®Google Scholar
• Wu J, Li S, Jia W, Deng H, Chen K, Zhu L, Yu F, Su F. Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer. PLoS One. 2015;10:e0133643. doi:10.1371/journal.pone.0133643. PMID:26218285
   PubMed Web of Science ®Google Scholar
• Xu C, Sun X, Qin S, Wang H, Zheng Z, Xu S, Luo G, Liu P, Liu J, Du N, et al. Let-7a regulates mammosphere formation capacity through Ras/NF-kappaB and Ras/MAPK/ERK pathway in breast cancer stem cells. Cell Cycle. 2015;14:1686–1697. doi:10.1080/15384101.2015.1030547.
   PubMed Web of Science ®Google Scholar
• Liu K, Zhang C, Li T, Ding Y, Tu T, Zhou F, Qi W, Chen H, Sun X. Let-7a inhibits growth and migration of breast cancer cells by targeting HMGA1. Int J Oncol. 2015;46:2526–2534. doi:10.3892/ijo.2015.2949.
   PubMed Web of Science ®Google Scholar
• Serguienko A, Grad I, Wennerstrom AB, Meza-Zepeda LA, Thiede B, Stratford EW, Myklebost O, Munthe E. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA. Oncotarget. 2015;6:2451–2465. doi:10.18632/oncotarget.3235.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Zhao S, Li Q, Li Y, Kawamoto K. Arsenic trioxide-mediated Notch pathway inhibition depletes the cancer stem-like cell population in gliomas. Cancer Lett. 2010;292:64–72. doi:10.1016/j.canlet.2009.11.005.
   PubMed Web of Science ®Google Scholar
• Hu J, Huang X, Hong X, Lu Q, Zhu X. Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway. Cancer Cell Int. 2013;13:25. doi:10.1186/1475-2867-13-25. PMID:23497375
   PubMed Web of Science ®Google Scholar
• Ding D, Lim KS, Eberhart CG. Arsenic trioxide inhibits Hedgehog, Notch and stem cell properties in glioblastoma neurospheres. Acta Neuropathol Commun. 2014;2:31. doi:10.1186/2051-5960-2-31. PMID:24685274
   PubMed Web of Science ®Google Scholar
• Wu J, Ji Z, Liu H, Liu Y, Han D, Shi C, Wang C, Yang G, Chen X, Shen C, et al. Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway. Toxicol Lett. 2013;220:61–69. doi:10.1016/j.toxlet.2013.03.019.
   PubMed Web of Science ®Google Scholar
• Yang MH, Zang YS, Huang H, Chen K, Li B, Sun GY, Zhao XW. Arsenic trioxide exerts anti-lung cancer activity by inhibiting angiogenesis. Curr Cancer Drug Targets. 2014;14:557–566. doi:10.2174/1568009614666140725090000.
   PubMed Web of Science ®Google Scholar
• Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH. Notch-1 induces epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells. Cancer Lett. 2011;307:26–36. doi:10.1016/j.canlet.2011.03.012.
   PubMed Web of Science ®Google Scholar
• Bao B, Wang Z, Ali S, Ahmad A, Azmi AS, Sarkar SH, Banerjee S, Kong D, Li Y, Thakur S, et al. Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells. Cancer Prev Res (Phila). 2012;5:355–364. doi:10.1158/1940-6207.CAPR-11-0299.
   PubMed Web of Science ®Google Scholar
• Bao B, Ali S, Banerjee S, Wang Z, Logna F, Azmi AS, Kong D, Ahmad A, Li Y, Padhye S, et al. Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression. Cancer Res. 2012;72:335–345. doi:10.1158/0008-5472.CAN-11-2182.
   PubMed Web of Science ®Google Scholar
• McCulloch D, Brown C, Iland H. Retinoic acid and arsenic trioxide in the treatment of acute promyelocytic leukemia: current perspectives. Onco Targets Ther. 2017;10:1585–1601.
   PubMed Web of Science ®Google Scholar
• Ma J, Fang B, Zeng F, Ma C, Pang H, Cheng L, Shi Y, Wang H, Yin B, Xia J, et al. Down-regulation of miR-223 reverses epithelial-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells. Oncotarget. 2015;6:1740–1749. doi:10.18632/oncotarget.2714.
   PubMed Web of Science ®Google Scholar
• Xia J, Duan Q, Ahmad A, Bao B, Banerjee S, Shi Y, Ma J, Geng J, Chen Z, Rahman KM, et al. Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells. Curr Drug Targets. 2012;13:1750–1756. doi:10.2174/138945012804545597.
   PubMed Web of Science ®Google Scholar
• Ma J, Cheng L, Liu H, Zhang J, Shi Y, Zeng F, Miele L, Sarkar FH, Xia J, Wang Z. Genistein down-regulates miR-223 expression in pancreatic cancer cells. Curr Drug Targets. 2013;14:1150–1156. doi:10.2174/13894501113149990187.
   PubMed Web of Science ®Google Scholar
• Yang Q, Wang Y, Lu X, Zhao Z, Zhu L, Chen S, Wu Q, Chen C, Wang Z. MiR-125b regulates epithelial-mesenchymal transition via targeting Sema4C in paclitaxel-resistant breast cancer cells. Oncotarget. 2015;6:3268–3279.
   PubMedGoogle Scholar